Medipal Holdings Corp ADR (MAHLY)

Medipal Holdings Corp ADR is a depositary receipt listed on OTC Markets that represents common stock in Medipal Holdings Corporation. The underlying issuer is a Japan-based healthcare-related group headquartered in Tokyo and founded in 1898. Its operations center on prescription pharmaceutical wholesale in Japan, alongside procurement and distribution of healthcare products used in diagnostics, testing, treatment, and clinical administration. The company also handles contract PMS services for manufacturers, distributes specialty pharmaceuticals, and is active in areas such as cosmetics, daily necessities, OTC medicines, animal health products, agricultural and fisheries raw materials, contract logistics, insurance agency services, medical coding and claims-related outsourcing, and database-related services for medical facilities. Medipal serves hospitals, clinics, pharmacies, drugstores, and other commercial and healthcare customers.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
OTC-MAHL.Y
$26.18
39.6% Upside
Undervalued
Not available
Not available
Great
0.0%
October 30, 2026
12.8x
0.9x
0.2x
3.779 B
1.296 B
0.0%
87.1%
6.1
85.7%
Valuation • Fair Value

Medipal Holdings Corp ADR (OTC-MAHL.Y) Fair Value by Valuation Model

Review the available estimates for Medipal Holdings Corp ADR (OTC-MAHL.Y), including DCF Fair Value, Ben Graham Formula Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$26.18

Estimated upside of 39.6% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$30.61

Discounted cash flow valuation reference.

Ben Graham Formula Value

$16.04

Classic Ben Graham valuation formula reference.

EPV Fair Value

$36.95

Earnings power value estimate.

Comps Fair Value

$19.97

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 6 available valuation references for Medipal Holdings Corp ADR (OTC-MAHL.Y) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Medipal Holdings Corp ADR (OTC-MAHL.Y)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

23.752 B

Current operating scale indicator.

Revenue Forecast

24.992 B

Forward revenue estimate.

EBITDA

511.4 M

Current operating profitability reference.

EBITDA Forecast

458.4 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Medipal Holdings Corp ADR (OTC-MAHL.Y) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Medipal Holdings Corp ADR (OTC-MAHL.Y)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Great

Positive financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-2.49

No elevated caution signal from this screen.

Altman Z-Score

6.1

Relatively strong balance-sheet zone.

FCF / Net Income

85.7%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Medipal Holdings Corp ADR (OTC-MAHL.Y). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Medipal Holdings Corp ADR (OTC-MAHL.Y)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

October 30, 2026

Days to Earnings

38

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Medipal Holdings Corp ADR (OTC-MAHL.Y), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Medipal Holdings Corp ADR (OTC-MAHL.Y) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Buy

The 1-hour technical read for Medipal Holdings Corp ADR (OTC-MAHL.Y) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Medipal Holdings Corp ADR (OTC-MAHL.Y) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Medipal Holdings Corp ADR (OTC-MAHL.Y) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Medipal Holdings Corp ADR (OTC-MAHL.Y) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ Fast Investor Answers

Medipal Holdings Corp ADR (OTC-MAHL.Y) Stock FAQ

Data-supported answers about Medipal Holdings Corp ADR (OTC-MAHL.Y), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$26.18
Estimated upside 39.6%
Valuation Rating
Undervalued
Estimated upside of 39.6%
Financial Health
Great
Current financial-health read

The current fair value estimate for Medipal Holdings Corp ADR (OTC-MAHL.Y) is $26.18. This implies an estimated upside of 39.6% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 39.6% versus the current market price.

The current financial health read for Medipal Holdings Corp ADR (OTC-MAHL.Y) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Medipal Holdings Corp ADR (OTC-MAHL.Y) is October 30, 2026.

The latest available data indicates no current dividend yield for Medipal Holdings Corp ADR (OTC-MAHL.Y).

The current P/E ratio listed for Medipal Holdings Corp ADR (OTC-MAHL.Y) is 12.8x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Medipal Holdings Corp ADR is 3.779 B.

The current enterprise value listed for Medipal Holdings Corp ADR is 1.296 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Medipal Holdings Corp ADR is OTC-MAHL.Y, and the stock is listed on OTC Markets.

Medipal Holdings Corp ADR (OTC-MAHL.Y) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Medipal Holdings Corp ADR is 0.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Medipal Holdings Corp ADR is 87.1%. Free float helps investors understand how much of the share base is available for public trading.